Afirm. (2013). Annual Report 2013: Technical Progress Reports, Armed Forces Institute of Regenerative Medicine, USA.
Aligica, P. D. (2006). Institutional and Stakeholder Mapping: Frameworks for Policy Analysis and Institutional Change. Public Organization Review, 6(1), 79–90. DOI: https://doi.org/10.1007/s11115-006-6833-0.
Badylak, S., & Rosenthal, N. (2008). Regenerative medicine: are we there yet? NPJ Regenerative Medicine, 2(1), 2. DOI: https://doi.org/10.1038/s41536-016-0005-9.
Bagheri Moghadam, N. (2008). Technological innovation systems. Research Institute of Iran's Sicence Policies.
Bagheri Moghadam, N., Mohamadi, K., & Jafari, MM. (2010). Government Position and Responsibilities in Technology Development Process. The Forth National Conference of Iran's Technology Management.
Bergek, A., Jacobsson, S., Carlsson, B., Lindmark, S., & Rickne, A. (2008). Analyzing the functional dynamics of technological innovation systems: a scheme of analysis, Research Policy, 37, 407–29.
Cambria, E., Pasqualini, F. S., Wolint, P., Günter, J., Steiger, J., Bopp, A., & Emmert, M. Y. (2017). Translational cardiac stem cell therapy: advancing from first-generation to next-generation cell types. NPJ Regenerative Medicine, 2(1), 17. DOI: https://doi.org/10.1038/s41536-017-0024-1.
CIRM. (2009-2010). Strategic plan update- accelerating the opportunity for cures, california institute for regenerative medicine.
Ghazinoury, S. S. (2002). Science and technology planning and policymaking- case study of nano technology in Iran. Presidential Office of Technology Cooperations.
Ghazinoury, S.S., Ghazinoury, S.S. (2008). Extracting solutions for reforming iran's national innovation system using comparative study of selected countries. Journal of Science and Technology Policy, 1(1), 65-81. Retrieved from https://www.sid.ir/fa/journal/ViewPaper.aspx?id=75973
Ghazinoury, S.S., Ghazinoury, S. S. (2012). An introduction to science, technology and innovation policymaking. Trabiat Modares University Publications.
Haan, G. d., Crom, R. d., Dzierzak, E., & Mummery, C. (2017). Regenerative medicine funding policies in europe and the netherlands. NPJ Regenerative Medicine, 2(1), 1. DOI: https://doi.org/10.1038/s41536-016-0006-8.
Hadavand, F., FatehRad, M., & Pezeshkian, H. (2016). Analyzing Policimaking Processes in Iran National Innovation System Using Instituational Mapping Framework. Journal of Strategic and Macro Policies, 4 (16), 1-18.
Hekkert, M., Suurs, R., Negro, S., Kuhlmann, S., & Smits, R. (2007). Functions of innovation systems: a new approach for analysing technological change. Technological Forecasting and Social Change, 74, 413–32
Lall, S. (2007). Technology policy and market encouragement. center of technology studies sharid university of technology, Rasa Publications.
Lu, Y. (2010). Science & technology in China: A roadmap to 2050: strategic general report of the Chinese Academy of Sciences / Yongxiang Lu, editor-in-chief, Springer, Heidelberg; London.
Lytal, C. (2014). New health facility aims to translate stem cell science into therapies. Pobrane z: http://news.usc.edu/62466/new-health-facility-aims-to-translate-stem-cell-science-into-treatment-therapies/.
Medical Research Council. (2012). A strategy for uk regenerative medicine, Medical Research Council, 2012.
Meyer, U. (2009). The history of tissue engineering and regenerative medicine in perspective. W: U. Meyer (red.), Fundamentals of Tissue Engineering and Regenerative Medicine (s. 5–12). Berlin, London: Springer. DOI: https://doi.org/10.1007/978-3-540-77755-7-1.
Mohamadi, M., Tabatabaian, SH., Elyasi, M., & Roshani, S. (2013). Analyzing the formation model of new technologies innovation system functions in iran- a case study of nano-technology sector. Journal of Science and Technology Policy, 5(4), 19-112.
Pharma Letter. (2018). Global regenerative medicine market expected to reach $67 billion by 2020. Pobrane z: https://www.thepharmaletter.com/article/global-regenerative-medicine-market-expected-to-reach-67-billion-by-2020.
Samanthi. (2017). Difference between tissue engineering and regenerative medicine. Pobrane z: https://www.differencebetween.com/difference-between-tissue-engineering-and-vs-regenerative-medicine/.
Science and Technology Committee. (2013). Regenerative medicine report, House of Lords, 1st Report of session 2013-14.
Sharifi, S., Naghipurfar, V., & Hamidizadeh, M. (2106). Identifying Strategic Resistance Economy in Holy Prophet's Manners. Strategic Management Studies, 23(8), 137- 181. Retrieved from http://www.smsjournal.ir/article_87880.html
Vacanti, C. A. (2006). The history of tissue engineering. journal of cellular and molecular medicine, 10(3), 569–576. DOI: https://doi.org/10.1111/j.1582-4934.2006.tb00421.x.
Williams, D., Archer, R., & Dent, A. (2010). Building a viable regenerative medicine industry- a guide for stakeholders. Loghborough University. ISBN9781907382185.
Young, E., & Quinn, L. (2002). Writing effective public policy papers: a guide for policy advisers in central and eastern europe. Open Society Institute.